Purchase Order 47QSWA24P00BC

Award Date 10/3/23
Potential Completion Date 6/10/25
Potential Value Not listed
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Milwaukee, WI 53202, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $21,000 to Pfizer Inc., doing business as Pfizer, for the delivery of ondansetron hydrochloride injection. The contract has a period of performance from August 18-23, 2023, with all work to be conducted at Pfizer's place of performance in New York, New York. The delivery order was issued against an existing indefinite-delivery/indefinite-quantity vehicle to supply pharmaceutical products in...
<p>This delivery order for $21 of ondansetron hydrochloride (PF) 4 mg/2 ml injections was awarded by the Defense Logistics Agency Troop Support Medical to Pfizer Inc. on August 22, 2023, with a completion date of August 25, 2023. The firm fixed price contract was issued under an existing vehicle to supply the agency's medical programs with the requested pharmaceutical products. No set-aside designation was applied to this award. Place of performance will be Pfizer's New York City location.</p>
This federal contract award is for the delivery of 30-count packages of 4 mg Ondansetron HCl tablets to the Medical Supply Chain, a defense agency of the Department of Defense. The $3,840.87 Firm Fixed Price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 28, 2024, with a completion date of August 29, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support...
This is a $1,191.01 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4 mg ondansetron hydrochloride tablets, a medication used to prevent nausea and vomiting. The award has a performance period through March 17, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award is for the delivery of 100 units of 8 mg ondansetron hydrochloride tablets, valued at $1,116.45, with an ultimate completion date of April 19, 2024. The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The award is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the...
The federal government awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,285,861 tablets of 8 mg ondansetron hydrochloride, a medication used to treat nausea and vomiting. The contract, valued at $16,173.65, was awarded by the Defense Logistics Agency (DLA) on July 29, 2024, with a completion date of July 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) the company holds with the DLA...
The U.S. government awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 4,563,358,978 units of Ondansetron HCL 4 mg tablets. The contract has a ceiling value of $12,144.43 and an ultimate completion date of January 22, 2024. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency that provides medical supply chain services. AmerisourceBergen holds a larger...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $75,440.91 firm fixed-price delivery order is for the supply of 500 packs of 8 mg Ondansetron HCl tablets. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and medical supplies for military healthcare...
This is a federal contract award with ID SPE2DX15D1053|SPE2DX25F6FQF to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,816,325 units of Ondansetron HCL 8 mg tablets, with a firm fixed price ceiling value of $15,898.90. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 through November 2026....
The Defense Logistics Agency Troop Support Medical awarded a $10,500 delivery order to Pfizer Inc. for the supply of ondansetron hydrochloride injection. The firm fixed price order is for 4561659181 units of the 4 mg/2 ml antiemetic drug to be delivered from Pfizer's New York City location between August 1-4, 2023. As a major provider of pharmaceuticals to the Department of Defense, this award supports DLA's mission to provide quality medical supplies to troops worldwide. No subcontractors or...

The General Services Administration awarded Pax Holdings, LLC a firm fixed price purchase order valued at seventy-nine thousand seven hundred seventy-five dollars ($79,775) to supply ondansetron hydrochloride injection. Performance will occur in Milwaukee, Wisconsin from October 3, 2023 through January 31, 2024. The award was made under GSA Advantage Contract V797D-50346, a multiple award schedule contract vehicle managed by the GSA Federal Acquisition Service to provide pharmaceutical products and services to government customers. Pax Holdings will deliver 250-count packages of ondansetron hydrochloride injection labeled for expiration on January 31, 2024. No subcontractors or additional context were indicated.

Generated 12/24/23, 6:34 AM